The Healthcare Navigator
The Healthcare Navigator
Segal projects medical plan cost trend at 9 percent for 2026, and Mercer puts specialty Rx trend at 15 percent. Cunningham v. Cornell, which lowered the bar for ERISA fiduciary breach claims at the pleading stage, turned network adequacy and pharmacy benefit manager (PBM) stewardship into fiduciary records. The audit value sits in your existing claims data.
A written readout of your last 24 months of claims, benchmarked against 2026 federal and national pricing data. Real numbers from your data. No broker swap required.
Cited inline
Projected 2026 medical plan cost trend (Segal)
Specialty Rx trend leading the pressure (Mercer)
OBBBA Medicaid cuts phased 2026 to 2028 (CBO / KFF)
Addressable spend a claims audit typically surfaces
Sources: Segal 2026 Trend Survey · Mercer 2026 Health Cost Outlook · CBO / KFF OBBBA analysis · THN audit experience
Washington has named the pricing problem. Congress has not solved it. Your next renewal won't wait for either of them.
Synthesis of Segal 2026 · Mercer 2026 · CBO / KFF OBBBA · RAND Round 5.1 · 2026 state DOI rate filings
01 · National at a glance
RAND Round 5.1 puts the national mean commercial-to-Medicare hospital pricing at roughly 254 percent of the Medicare rate. State filings range from under 175 percent in Washington to over 340 percent in Georgia. On January 1, the Wasteful and Inappropriate Service Reduction (WISeR) Medicare pilot goes live in six states, and the One Big Beautiful Bill Act (OBBBA) Medicaid cuts phase in through 2028. Cunningham v. Cornell now sets the pleading standard for every ERISA plan. Renewal math doesn't isolate you from any of it.
02 · Pricing pressure
The 2026 Affordable Care Act (ACA) gross rate filings run from roughly +8 percent in parts of the Midwest to +28 percent or more in Colorado and Florida. Inside that distribution, the same hospital procedure runs at 175 percent of the Medicare rate in Washington and 344 percent in Georgia (RAND Round 5.1). On top of that, Mercer's 2026 specialty Rx trend lands at +15 percent, the largest single line item in this year's cost story. The same broader-market signal feeds every renewal model.
RAND Round 5.1 · state DOI 2026 filings · Mercer 2026 · KFF
A 100-employee plan with members in Colorado, Georgia, and Florida is being benchmarked against the +28 percent tail of the rate filings and the high end of the RAND curve, not the +9 percent national trend line the carrier puts at the top of the renewal letter. The +15 percent specialty Rx pressure sits on top of that. The audit work starts with finding where your claims actually fall on the curve and naming the steering, pharmacy-benefit, and behavioral health decisions that move you off the high end.
03 · The 2026 calendar
Six federal events are landing on self-funded plans over the next twelve months. Each one is already baked into your 2026 renewal and your fiduciary documentation requirements whether you've seen it or not.
Segal's 2026 Trend Survey puts active-employee medical plan cost trend at 9 percent. Mercer's 2026 Health Cost Outlook puts specialty Rx at 15 percent, which is what's pulling the headline number up. Carriers don't separate your claims from the market's; both numbers feed the same renewal model.
The Wasteful and Inappropriate Service Reduction (WISeR) Model launches in six pilot states on January 1: Ohio, New Jersey, Arizona, Oklahoma, parts of Texas, and Washington. WISeR governs Medicare prior authorization (PA) on selected services, not commercial plans directly. Commercial PA has historically tightened 12 to 18 months behind Medicare, as systems normalize tighter criteria across their payer mixes. The denial calls and bill-shock escalations land on your benefits desk regardless of how your plan is funded.
The Consolidated Appropriations Act 2026 (CAA 2026) strengthens employer-side disclosure rights into pharmacy benefit manager (PBM) rebates and spread pricing. Plan sponsors now have a statutory hook for renewal-stage conversations they couldn't force before. Whatever documentation comes back has to hold up where Cunningham now makes it discoverable.
OBBBA pulls more than 1 trillion dollars out of Medicaid over the phased 2026 to 2028 window, with an estimated 16 million coverage loss flowing through state redetermination programs. Uninsured residents still get care at the ER; hospitals recover that cost by charging commercial payers more. Self-funded employers absorb a hidden tax on every uninsured emergency room (ER) visit in their service area.
The enhanced Affordable Care Act (ACA) premium tax credits expired at the end of 2025. Marketplace premiums move sharply in many states as a result. Workers who lose individual coverage move onto their employer's plan, which means more enrolled lives, more risk-pool concentration, and a sharper signal feeding next year's stop-loss renewal.
The Cunningham pleading standard is now operative for every plan administrator. Personal fiduciary exposure attaches to plan administrators, not just the plan sponsor entity. Alongside that, the Department of Labor (DOL) continues its 2026 audit focus on non-quantitative treatment limitation (NQTL) comparative analysis documentation under the federal Mental Health Parity and Addiction Equity Act (MHPAEA), even as broader parity enforcement policy at the federal level shifts. Your NQTL comparative analysis has to hold up to the new bar.
04 · Four mechanics specific to 2026
Hits the CFO line
The One Big Beautiful Bill Act (OBBBA) cuts more than 1 trillion dollars from Medicaid over the phased 2026 to 2028 window and runs a redetermination wave that projects roughly 16 million in coverage loss. Uninsured residents still need care; hospital systems absorb the uncompensated cost and negotiate higher commercial rates to offset. Stop-loss carriers price against the broader market regardless of your own claims experience, which means your renewal moves with that broader signal whether your members live in expansion states or not. This is a federal mechanism your CFO line absorbs.
[1] CBO / KFF OBBBA analysis, 2025 · [2] RAND Round 5.1 hospital pricing dataHits the Total Rewards story
Mercer's 2026 Health Cost Outlook puts specialty Rx trend at 15 percent. GLP-1 utilization adds to it. The Consolidated Appropriations Act 2026 (CAA 2026) gives Total Rewards a statutory hook into PBM rebates, pharmacy spread, and formulary decisions for the first time. The Cunningham pleading bar means whatever the PBM hands back becomes part of your fiduciary record. Pull the transparency package apart, find where the rebate flow doesn't reconcile to your formulary, and that becomes the renewal-stage lever.
[3] Mercer 2026 Health Cost Outlook · [4] CAA 2026 statutory text · [5] Cunningham v. Cornell, U.S. Supreme Court, April 2025Hits the CHRO talent story
The Department of Labor (DOL) 2026 focus on non-quantitative treatment limitation (NQTL) comparative analysis documentation continues even as broader federal parity enforcement policy shifts, and the Cunningham bar now applies to plan administrators personally. A new hire calls the number on her ID card on a Tuesday afternoon and is told the next behavioral health appointment is fourteen weeks out. She tells two coworkers. The summary plan description she signed at orientation said her mental health benefit was equivalent to her medical benefit, and the ERISA exemption doesn't appear anywhere in that document.
[6] DOL 2026 NQTL audit focus · [7] Cunningham v. Cornell · [8] MHPAEA 2024 final rulesHits the benefits desk
The WISeR pilot launches January 2026 in six states (Ohio, New Jersey, Arizona, Oklahoma, parts of Texas, Washington) and governs Medicare fee-for-service, not commercial plans directly. What happens next is the part you should plan for: commercial payers have historically followed Medicare PA tightening inside 12 to 18 months. Providers respond to tighter Medicare criteria by raising the bar on commercial PA too. Bill-shock calls and PA-denial escalations land on the benefits desk regardless of how your plan is funded.
[9] CMS WISeR Model documentation · [10] Commercial PA pattern reporting05 · Run this brief against your own plan
The sections above describe what's hitting in 2026. The numbers that matter most are the ones inside your own plan. Here are the three places we look first, regardless of which states your members live in.
Carriers don't separate your claims from the market's. The OBBBA cost-shift mechanism shows up as a federal commercial repricing pattern in every state your members live in. Pull the carrier's renewal narrative apart and ask what they're actually attributing the move to, then look at how much of it is broader-market repricing versus claims you can act on.
The Consolidated Appropriations Act 2026 (CAA 2026) gives Total Rewards documented disclosure rights into PBM rebates, spread pricing, and formulary decisions. Read what came back from the PBM against Mercer's +15 percent specialty Rx trend and against your own GLP-1 utilization. If the rebate flow doesn't reconcile to the formulary on file, that's the gap. Whatever is on your desk has to match what a Cunningham-era plaintiff would point at.
The Department of Labor (DOL) 2026 audit focus on non-quantitative treatment limitation (NQTL) comparative analysis documentation is active, and the federal Mental Health Parity and Addiction Equity Act (MHPAEA) 2024 final rules apply to every Employee Retirement Income Security Act (ERISA) plan. Run two tests. First, an operational one: pick a member, pick a metro, and verify a behavioral health (BH) provider with real availability inside seven days. Second, a documentation one: pull your NQTL comparative analysis and read it the way a plaintiff's lawyer would post-Cunningham.
06 · The Healthcare Navigator in 2026
Every 2026 federal change hits the renewal at once. A government fix is years away and won't arrive in time for your next renewal. What you can move now is what sits inside the plan: the steering work at the member's care decision point, the PBM transparency package converted into renewal leverage, and the documentation that ends up in the navigator's records.
Before your member books a procedure, a clinical navigator on our team walks them through their options and routes them to the highest-value one, anchored to national benchmarks (RAND Round 5.1, ambulatory alternatives, peer-hospital pricing in your members' actual network). The right care setting at the right price, judged on outcome data and not just whether the facility is in-network.
AI-driven guidance and nurse advocacy applied to your specialty Rx spend, GLP-1 utilization, and chronic-disease cohort, with the Consolidated Appropriations Act 2026 (CAA 2026) transparency package converted into renewal-stage negotiation leverage on your pharmacy benefit manager (PBM). The fiduciary documentation that comes with it holds up under the Cunningham pleading standard.
Twenty-four months of your claims, benchmarked against 2026 federal pricing data, the RAND Round 5.1 commercial-to-Medicare distribution, and the national specialty Rx and behavioral health access baseline. The 15 to 22 percent addressable-spend finding holds. The readout breaks down where that 15 to 22 percent sits, by section of your spend.
The deliverable
Two weeks after you send the data, you get a written analysis (not a slide deck). We map your spend against the 2026 federal pricing data and the RAND Round 5.1 national commercial-to-Medicare distribution, surface the personalized member-cost picture for your geographies, and lay out what the next twelve months look like if nothing changes.
07 · Common questions
08 · Self-funded employers, real results
Ylonda Tomlinson
CHRO · 360-person professional services firm, Mid-Atlantic
"This was a game-changer. Our claims dropped 23% in eight months. I finally understand my own plan."
Marcus R.
CFO · 240-person manufacturing company, Midwest
"They found $740K in year one. I thought my broker was good. Turns out he just wasn't telling me everything."
Your last 24 months of claims, read against 2026 federal pricing data and the RAND Round 5.1 national commercial-to-Medicare distribution. Written readout in two weeks. Real numbers from your data. No broker swap required.
For U.S. self-funded employers · 100 to 2,000 active participants
Sources & evidence anchors
[1] Segal 2026 Health Plan Cost Trend Survey — +9 percent projected 2026 medical plan cost trend for active-employee plans
[2] Mercer 2026 Health Cost Outlook — +15 percent specialty Rx trend leading total plan cost growth; GLP-1 utilization context
[3] Congressional Budget Office (CBO) and Kaiser Family Foundation (KFF) — One Big Beautiful Bill Act (OBBBA) analysis: ~$1T+ Medicaid funding cuts phased 2026 to 2028; ~16 million projected coverage loss
[4] RAND Hospital Price Transparency Study Round 5.1 (2022 data, published May 2024) — national mean commercial-to-Medicare ~254 percent; state range <175 percent (WA) to >340 percent (GA); outliers exceed 600 percent
[5] CMS Wasteful and Inappropriate Service Reduction (WISeR) Model documentation — January 2026 pilot in OH, NJ, AZ, OK, parts of TX, WA; Medicare prior authorization scope
[6] Consolidated Appropriations Act 2026 (CAA 2026) — pharmacy benefit manager (PBM) transparency provisions strengthening employer-side fiduciary visibility into rebates, pharmacy spread, and formulary decisions
[7] Cunningham v. Cornell, 604 U.S. ___ (April 17, 2025) — Supreme Court decision lowering the bar for ERISA fiduciary breach claims at the pleading stage; personal fiduciary exposure for plan administrators
[8] Affordable Care Act enhanced premium tax credit expiration analysis (end of 2025) — KFF, CBO, and state DOI marketplace coverage-loss projections
[9] 2026 state DOI ACA gross rate filings — range from roughly +8 percent (parts of Midwest) to +28 percent or more (CO, FL Blue +27 percent, OH +19.8 percent, NY with PBM repricing); collected via ACA Signups and state DOI publications
[10] Department of Labor (DOL) 2026 audit focus — non-quantitative treatment limitation (NQTL) comparative analysis documentation under the federal Mental Health Parity and Addiction Equity Act (MHPAEA) 2024 final rules
[11] KFF mental health access reporting — 7-day behavioral health appointment availability gap; national network adequacy data
[12] THN audit experience — 15 to 22 percent addressable-spend finding across 24-month claims audits for self-funded employer plans, 100 to 2,000 active participants
© The Healthcare Navigator — Better Care. Better Benefits. For U.S. self-funded employers.
Contact